Applied Molecular Transport Inc. (AMTI) Stock Analysis
DELISTED 2023
What happened to Applied Molecular Transport Inc. (AMTI) stock?
Applied Molecular Transport Inc. (AMTI) no longer trades on public markets. It was delisted in December 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2023
- Last recorded price (historical):
- $0.263 (last quote on record before the December 2023 delisting; historical, not a current quote)
Market cap $11.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Applied Molecular Transport Inc. (AMTI). Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company focused on developing oral and respiratory biologics. Their lead product, AMT-101, is in Phase II clinical trials for ulcerative colitis.
Last analyzed: May 10, 2026Applied Molecular Transport Inc. (AMTI) Healthcare & Pipeline Overview
More about this archive record
Can I still buy AMTI shares?
No. AMTI stopped trading on public markets in December 2023, so the shares are not available through a broker. Anything you see quoted for AMTI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before AMTI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Applied Molecular Transport Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.